ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.

The discussions highlighted the crucial role of prevention, treatment and access to immunisation programmes to raise awareness and decrease the cases of RSV hospitalisations and deaths of young children and older adults.

Conclusions by Peter Openshaw, Co-Chair of the the ESWI Respiratory Virus Summit 2024

How to ensure/prepare for access to immunisation programmes

By Ab Osterhaus, Host of the ESWI Respiratory Virus Summit 2024

Live attenuated vaccines; NIRSE-GAL: Evaluation of the effectiveness and impact of Nirsevimab in Galicia; and Therapeutics

ESWI Summit 2024: Early Career Scientists They each delivered a presentation introducing themselves and their ongoing work on RSV, bringing innovative ideas and making clear calls for action.

Keynote Lecture by Dexter Wiseman, Imperial College London

Keynote Lecture by Stefan Gravenstein, Brown University

Keynote Lecture by Simon Drysdale, St George's University Hospitals NHS Foundation Trust

From the ESWI Respiratory Virus Summit 2024

From the ESWI Respiratory Virus Summit 2024